Aligos Therapeutics, Inc.
ALGS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001799448
No open-market purchases or sales by Aligos Therapeutics, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $13.2M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
13F holders, Q4 2025
Institutional positions in Aligos Therapeutics, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- +8 vs. Q3 2025
- Shares held
- 2.81M
- +159.5K (+6.0%) vs. Q3 2025
- Total value
- $26.2M
- +$208.1K (+0.8%) vs. Q3 2025
- New holders
- 13
- 9 more added
- Sold out
- 5
- 7 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALGS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 31 | $13.2M |
| Q1 2026 | 35 | $20.6M |
| Q4 2025 | 41 | $26.2M |
| Q3 2025 | 33 | $26.0M |
| Q2 2025 | 37 | $19.5M |
| Q1 2025 | 35 | $27.1M |
| Q4 2024 | 34 | $64.5M |
| Q3 2024 | 27 | $14.7M |
| Q2 2024 | 49 | $16.6M |
| Q1 2024 | 49 | $45.3M |
| Q4 2023 | 40 | $30.1M |
| Q3 2023 | 36 | $19.2M |
| Q2 2023 | 41 | $25.5M |
| Q1 2023 | 46 | $23.9M |
| Q4 2022 | 39 | $25.3M |
| Q3 2022 | 52 | $30.4M |
| Q2 2022 | 60 | $36.0M |
| Q1 2022 | 76 | $68.4M |
| Q4 2021 | 71 | $390.4M |
| Q3 2021 | 68 | $483.9M |
| Q2 2021 | 58 | $550.5M |
| Q1 2021 | 52 | $612.4M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Aligos Therapeutics, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Deep Track Capital, LP | 444,110 | $4.14M | 0.09% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 412,000 | $3.84M | 0.01% | 00.0% | Unchanged |
| Sio Capital Management, LLC | 335,937 | $3.13M | 0.52% | 00.0% | Unchanged |
| Woodline Partners LP | 289,169 | $2.70M | 0.01% | −179,030−38.2% | Reduced |
| Marshall Wace, LLP | 268,664 | $2.50M | 0.00% | +268,664 | New |
| Vanguard Group Inc | 200,395 | $1.87M | 0.00% | +28,706+16.7% | Added |
| SummitTX Capital, L.P. | 139,424 | $1.30M | 0.04% | +139,424 | New |
| Renaissance Technologies LLC | 85,444 | $796.3K | 0.00% | +30,425+55.3% | Added |
| Baker Bros. Advisors LP | 83,055 | $774.1K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 80,649 | $751.6K | 0.00% | +41,654+106.8% | Added |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 76,247 | $710.6K | 0.02% | 00.0% | Unchanged |
| Verition Fund Management LLC | 71,254 | $664.1K | 0.00% | +71,254 | New |
| LPL Financial LLC | 66,000 | $615.1K | 0.00% | +10,880+19.7% | Added |
| Citadel Advisors LLC | 51,834 | $483.1K | 0.00% | +41,524+402.8% | Added |
| Geode Capital Management, LLC | 47,741 | $445.1K | 0.00% | +661+1.4% | Added |
| Jane Street Group, LLC | 24,293 | $226.4K | 0.00% | +24,293 | New |
| XTX Topco Ltd | 23,053 | $214.9K | 0.01% | +23,053 | New |
| Quest Partners LLC | 13,876 | $129.3K | 0.01% | +7,104+104.9% | Added |
| Bank of America Corp | 13,108 | $122.2K | 0.00% | +11,194+584.8% | Added |
| BlackRock, Inc. | 13,040 | $121.5K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 13,000 | $121.2K | 0.00% | +13,000 | New |
| DRW Securities, LLC | 11,950 | $111.4K | 0.01% | +11,950 | New |
| HRT Financial LP | 11,374 | $106.0K | 0.00% | +11,374 | New |
| Rockefeller Capital Management L.P. | 10,000 | $93.2K | 0.00% | +9,000+900.0% | Added |
| NorthCrest Asset Manangement, LLC | 10,000 | $84.1K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 4,972 | $46.3K | 0.00% | +4,972 | New |
| Golden State Wealth Management, LLC | 2,674 | $24.9K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 2,520 | $23.5K | 0.00% | −8,764−77.7% | Reduced |
| Royal Bank of Canada | 2,125 | $20.0K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 1,500 | $14.0K | 0.00% | −1,670−52.7% | Reduced |
| Clear Street Markets LLC | 500 | $4.66K | 0.00% | +500 | New |
| Global Retirement Partners, LLC | 400 | $3.73K | 0.00% | −400−50.0% | Reduced |
| Wealth Enhancement Advisory Services, LLC | 0 | $3.50K | 0.00% | 0 | New |
| UBS Group AG | 364 | $3.39K | 0.00% | −15,818−97.8% | Reduced |
| JPMorgan Chase & Co | 306 | $2.85K | 0.00% | −402−56.8% | Reduced |
| Triumph Capital Management | 135 | $1.26K | 0.00% | +135 | New |
| Tower Research Capital LLC (TRC) | 39 | $363 | 0.00% | −418−91.5% | Reduced |
| SBI Securities Co., Ltd. | 26 | $242 | 0.00% | 00.0% | Unchanged |
| ZRC Wealth Management, LLC | 4 | $38 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 3 | $28 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 1 | $9 | 0.00% | +1 | New |
| Readystate Asset Management LP | 0 | $0 | 0.00% | −203,113−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −140,000−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −30,493−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −10,107−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −15−100.0% | Sold out |